Victoria Socha
Articles by Victoria Socha
Higher cardiovascular mortality risk was associated with higher CKM syndrome stage, research showed.
A dual SGLT inhibitor may have ischemic benefits for patients with CKD, T2D, and cardiovascular risks, a study found.
An analysis of CKD trials supported 3-year total slope as the primary slope-based outcome in randomized trials.
Cyclophosphamide-rituximab therapy and minimal use of glucocorticoids in ANCA-associated vasculitis may reduce morbidity.
The race of patients with ADPKD affects waitlist experience, allograft quality, and post-transplant outcomes, a study found.
A study of real-world data found that tolvaptan reduced long-term kidney function decline in ADPKD.
Using serum cystatin C as a biomarker for AKI could prove to be a valuable addition to diagnostic protocols, a study reports.
Researchers examined the effects of the GLP-1RA cotadutide on UACR, glycemic control, and body weight.
A meta-analysis examined the risk of CKD in patients with metabolic dysfunction-associated fatty liver disease.
An analysis Identified SIRT1, BAG3, COKN1A and FOS as potential autophagy-related biomarkers for IgAN.
Research identified microRNA-483-5p as a possible biomarker for IgA nephropathy to help with risk stratification.
A survey sought insight on nephrologists' practices and perceptions about reproductive care for women with kidney disease.
A study examined the effects of SGLT2i on eGFR slope in patients with autosomal dominant polycystic kidney disease.
Researchers at SCM25 presented interim results of the SPARTAN trial of sparsentan as a treatment for patients with IgAN.
One-year results of the AFFINITY trial of atrasentan to treat proteinuria among patients with IgAN were presented at SCM25.
Researchers presented results of an interim analysis of a study of finerenone among patients with CKD and type 2 diabetes.
Researchers assessed the burden of cardiovascular-kidney-metabolic (CKM) syndrome using NHANES 2001-2020 data.
Research examined outcomes associated with blood volume monitoring for patients on hemodialysis and hospitalized with HF.
Research explored kidney outcomes among young patients receiving glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
A study compared the impact of conservative management of CKD vs transition to dialysis on risk for cognitive dysfunction.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.